What U.S. Data Should be Used to Measure the Price Elasticity of Demand for Alcohol? Dec 01, 2012 By Christopher J. RuhmAlison Snow JonesKerry Anne McGearyWilliam C. KerrJoseph V. TerzaRavi S. PandianThomas K. Greenfield What U.S. Data Should be Used to Measure the Price Elasticity of Demand for Alcohol? This paper examines how estimates of the price elasticity of demand for beer vary with the choice of alcohol price series examined. Our most important finding is that the commonly used ACCRA price data are unlikely to reliably indicate alcohol demand elasticities—estimates obtained from this source vary drastically and unpredictably. As an alternative, researchers often use beer taxes to proxy for alcohol prices. While the estimated beer taxes elasticities are more stable, there are several problems with using taxes, including difficulties in accounting for cross-price effects. We believe that the most useful estimates reported in this paper are obtained using annual Uniform Product Code (UPC) “barcode” scanner data on grocery store alcohol prices. These estimates suggest relatively low demand elasticity, probably around -0.3, with evidence that the elasticities are considerably overstated in models that control for beer but not wine or spirits prices. Journal of Health Economics Journal of Health Economics Areas of focus Economics Christopher J. Ruhm Christopher J. Ruhm is a professor of public policy and economics at the Frank Batten School of Leadership and Public Policy. Ruhm’s recent research has focused on the role of government policies in helping parents with young children balance the competing needs of work and family life, and on examining how various aspects of health are produced – including the growth and sources of drug poisoning deaths in the United States, the rise in obesity and the relationship between macroeconomic conditions and health. Read full bio Alison Snow Jones Kerry Anne McGeary William C. Kerr Joseph V. Terza Ravi S. Pandian Thomas K. Greenfield Related Content Christopher J. Ruhm Estimated Prevalence of and Factors Associated With Clinically Significant Anxiety and Depression Among US Adults During the First Year of the COVID-19 Pandemic Research How much did clinically significant anxiety and depression increase among US adults during the first year of the COVID-19 pandemic? In this survey study of more than 1.4 million respondents in the US Behavioral Risk Factor Surveillance System survey, responses to a screening question calibrated to a 4-item Patient Health Questionnaire score of 6 or greater suggested that aggregate prevalence of clinically significant anxiety and depression increased only modestly overall among US adults in 2020 compared with 2017 to 2019. The Opioid Crisis, Health, Healthcare, and Crime: A Review Of Quasi-Experimental Economic Studies Research This study reviews quasi-experimental studies that examine the relationship between opioids and health and healthcare, and crime outcomes in the U.S. Ruhm Named SEA Distinguished Fellow News Chris Ruhm, Batten professor of public policy and economics, has received a Distinguished Fellow Award from the Southern Economic Association in recognition for his “substantial record of exceptional scholarly achievement and long-term involvement and service to the association.” Batten Showcase 2022: Family and Medical Leave Policies in the US: Where We Are and How We Got Here ft. Chris Ruhm News In this lecture, professor of public policy and economics at the Frank Batten School of Leadership and Public Policy, Chris Ruhm, discusses family medical leave policy in the United States. Ruhm looks at where we are now, how we got here and how to move forward.
Christopher J. Ruhm Christopher J. Ruhm is a professor of public policy and economics at the Frank Batten School of Leadership and Public Policy. Ruhm’s recent research has focused on the role of government policies in helping parents with young children balance the competing needs of work and family life, and on examining how various aspects of health are produced – including the growth and sources of drug poisoning deaths in the United States, the rise in obesity and the relationship between macroeconomic conditions and health. Read full bio
Estimated Prevalence of and Factors Associated With Clinically Significant Anxiety and Depression Among US Adults During the First Year of the COVID-19 Pandemic Research How much did clinically significant anxiety and depression increase among US adults during the first year of the COVID-19 pandemic? In this survey study of more than 1.4 million respondents in the US Behavioral Risk Factor Surveillance System survey, responses to a screening question calibrated to a 4-item Patient Health Questionnaire score of 6 or greater suggested that aggregate prevalence of clinically significant anxiety and depression increased only modestly overall among US adults in 2020 compared with 2017 to 2019.
The Opioid Crisis, Health, Healthcare, and Crime: A Review Of Quasi-Experimental Economic Studies Research This study reviews quasi-experimental studies that examine the relationship between opioids and health and healthcare, and crime outcomes in the U.S.
Ruhm Named SEA Distinguished Fellow News Chris Ruhm, Batten professor of public policy and economics, has received a Distinguished Fellow Award from the Southern Economic Association in recognition for his “substantial record of exceptional scholarly achievement and long-term involvement and service to the association.”
Batten Showcase 2022: Family and Medical Leave Policies in the US: Where We Are and How We Got Here ft. Chris Ruhm News In this lecture, professor of public policy and economics at the Frank Batten School of Leadership and Public Policy, Chris Ruhm, discusses family medical leave policy in the United States. Ruhm looks at where we are now, how we got here and how to move forward.